Media stories about Transcat (NASDAQ:TRNS) have trended somewhat positive on Wednesday, according to Accern. The research group identifies positive and negative media coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Transcat earned a coverage optimism score of 0.07 on Accern’s scale. Accern also gave media headlines about the scientific and technical instruments company an impact score of 45.2783164859879 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.
Shares of Transcat (TRNS) traded up 1.12% during mid-day trading on Wednesday, hitting $13.50. The company had a trading volume of 701 shares. The firm has a market capitalization of $96.24 million, a price-to-earnings ratio of 21.43 and a beta of 0.37. Transcat has a 52-week low of $10.00 and a 52-week high of $14.05. The firm has a 50-day moving average price of $13.02 and a 200 day moving average price of $12.40.
Transcat (NASDAQ:TRNS) last posted its earnings results on Tuesday, July 25th. The scientific and technical instruments company reported $0.12 earnings per share for the quarter. Transcat had a net margin of 3.03% and a return on equity of 10.37%. The firm had revenue of $36.28 million during the quarter. Analysts expect that Transcat will post $0.64 earnings per share for the current year.
Separately, Dougherty & Co started coverage on Transcat in a report on Wednesday, August 23rd. They issued a “buy” rating and a $20.00 price target for the company.
COPYRIGHT VIOLATION NOTICE: This story was reported by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this story on another domain, it was illegally stolen and republished in violation of international trademark & copyright legislation. The original version of this story can be viewed at https://stocknewstimes.com/2017/09/13/transcat-trns-earns-daily-media-impact-score-of-0-07.html.
In other Transcat news, Director Carl E. Sassano sold 7,500 shares of the business’s stock in a transaction on Monday, July 31st. The shares were sold at an average price of $13.02, for a total value of $97,650.00. Following the completion of the transaction, the director now owns 79,075 shares in the company, valued at $1,029,556.50. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Paul D. Moore sold 4,000 shares of the business’s stock in a transaction on Friday, August 4th. The stock was sold at an average price of $13.00, for a total transaction of $52,000.00. Following the completion of the transaction, the director now owns 57,698 shares of the company’s stock, valued at approximately $750,074. The disclosure for this sale can be found here. Insiders own 8.80% of the company’s stock.
Transcat Company Profile
Transcat, Inc is a provider of calibration and laboratory instrument services and a distributor of professional grade test, measurement and control instrumentation. The Company conducts its business through two segments: service (Service) and distribution (Distribution). Through the Service segment, the Company offers calibration, repair, inspection, analytical qualifications, preventative maintenance and other related services, a majority of which are processed through its asset management system, CalTrak (CalTrak).
Receive News & Ratings for Transcat Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat Inc. and related companies with MarketBeat.com's FREE daily email newsletter.